Lessons From Immune Checkpoint Inhibitor Trials in Hepatocellular Carcinoma

The implementation of immune checkpoint inhibitors (ICI) into the clinical management of different malignancies has largely changed our understanding of cancer treatment. After having proven efficacy in different tumor entities such as malignant melanoma and lung cancer, ICI were intensively tested...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Immunol
Main Authors: Mohr, Raphael, Jost-Brinkmann, Fabian, Özdirik, Burcin, Lambrecht, Joeri, Hammerich, Linda, Loosen, Sven H., Luedde, Tom, Demir, Münevver, Tacke, Frank, Roderburg, Christoph
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2021
Assuntos:
Immunology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8042255/
https://ncbi.nlm.nih.gov/pubmed/33859646
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.652172
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados